Chief Medical Officer, DaVita Healthcare Partners; Emeritus Professor of Medicine, David Geffen School of Medicine at UCLA
Nephrology
Dr. Allen R. Nissenson, MD
|
|
Give Review
Dr. Allen R. Nissenson practices Nephrology. He attended Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19 in research and 29 in primary care medicine He over the years received 2 awards: "Fellow (ASNF)" and "Whos Who in Medicine and Healthcare". Allen Nissenson is also published. He has 96 publications published. The lastest publication: "Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis.'
Publications
- Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis.
- Socioeconomic Status of Counties Where Dialysis Clinics Are Located Is an Important Factor in Comparing Dialysis Providers.
- Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis.
- For-profit dialysis providers.
- The Evolving Role of the Medical Director of a Dialysis Facility.
- Elderly patients starting outpatient dialysis not at excessive mortality risk.
- Guiding Principles and Checklist for Population-Based Quality Metrics.
- Impact of Age, Race and Ethnicity on Dialysis Patient Survival and Kidney Transplantation Disparities.
- Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients.
- PD First: Peritoneal Dialysis as the Default Transition to Dialysis Therapy.
- Improving Outcomes for ESRD Patients: Shifting the Quality Paradigm.
- Effect of Age and Dialysis Vintage on Obesity Paradox in Long-term Hemodialysis Patients.
- Creating an open dialogue on improving dialysis care.
- Nutritional predictors of early mortality in incident hemodialysis patients.
- Mortality Predictability of Body Size and Muscle Mass Surrogates in Asian vs White and African American Hemodialysis Patients.
- Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients.
- Toward population management in an integrated care model.
- Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials.
- Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
- CathAway fistula vascular access program achieves improved outcomes and sets a new standard of treatment for end-stage renal disease.
- Comparing Mortality of Peritoneal and Hemodialysis Patients in the First 2 Years of Dialysis Therapy: A Marginal Structural Model Analysis.
- Dialysis at a Crossroads--Part II: A Call for Action.
- What Can Dialysis Unit Medical Directors Do to Reduce Hospitalizations and Death?: Should Medical Directors Assume Responsibility for Facility-Specific Outcomes?
- Charlson comorbidity score is a strong predictor of mortality in hemodialysis patients.
- FOCUSED CLINICAL CAMPAIGN IMPROVES MINERAL AND BONE DISORDER OUTCOMES.
- Novel Lipoprotein Subfraction and Size Measurements in Prediction of Mortality in Maintenance Hemodialysis Patients.
- Association of Pretransplant Glycemic Control With Posttransplant Outcomes in Diabetic, Kidney-Transplant Recipients.
- Association of Pretransplant Serum Phosphorus with Posttransplant Outcomes.
- High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients.
- Racial and Ethnic Differences in the Association of Body Mass Index and Survival in Maintenance Hemodialysis Patients.
- Dialyzer reuse with peracetic Acid does not impact patient mortality.
- Role of Nutritional Status and Inflammation in Higher Survival of African American and Hispanic Hemodialysis Patients.
- The ESRD Demonstration Project: what it accomplished. DaVita Inc.
- Associations of Pretransplant Weight and Muscle Mass with Mortality in Renal Transplant Recipients.
- Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus.
- The 2011 ESRD prospective payment system: perspectives from DaVita, a for-profit large dialysis organization.
- Dialysis at a crossroads: 50 years later.
- Content validation of two SF-36 subscales for use in type 2 diabetes and non-dialysis chronic kidney disease-related anemia.
- Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients.
- Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients.
- A 'quiet revolution' in nephrology.
- The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.
- Dietary potassium intake and mortality in long-term hemodialysis patients.
- Anemia management in chronic kidney disease.
- Association of relatively low serum parathyroid hormone with malnutrition-inflammation complex and survival in maintenance hemodialysis patients.
- Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease.
- The 2009 proposed rule for prospective ESRD payment: perspectives from a large dialysis organization.
- Association of hemodialysis treatment time and dose with mortality and the role of race and sex.
- Technological advances in renal replacement therapy: five years and beyond.
- Bottom-up nanotechnology: the human nephron filter.
- Renal replacement therapy in the elderly.
- Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients.
- Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
- Is there "cherry picking" in the ESRD Program? Perceptions from a Dialysis Provider Survey.
- Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
- Applying frail-elderly care principles.
- High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine.
- Chronic kidney disease in the United States: a public policy imperative.
- Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
- Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis.
- Racial differences in mortality and ESRD.
- Epoetin-associated pure red cell aplasia: past, present, and future considerations.
- Race, gender, and socioeconomic disparities in CKD in the United States.
- Disease management in chronic kidney disease.
- Epoetin dosing and dialysis facility ownership.
- The future of renal replacement therapy.
- Influence of industry on renal guideline development commentary: keeping our eye on the ball and improving chronic kidney disease patient outcomes.
- Septicemia in patients with ESRD is associated with decreased hematocrit and increased use of erythropoietin.
- The case for disease management in chronic kidney disease.
- Economic burden of anemia in an insured population.
- Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis.
- Dialysis outcomes as a measure of adequacy of dialysis.
- Pure red-cell aplasia and epoetin therapy.
- Improving outcomes in CKD and ESRD patients: carrying the torch from training to practice.
- Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment.
- Economics of clinical nephrology practice.
- Role of sodium and volume in the pathogenesis of hypertension in hemodialysis.
- Restructuring the ESRD payment system in the United States.
- Anemia and its clinical consequences in patients with chronic diseases.
- Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature.
- What common practices in dialysis units can be altered to improve patient care?
- Emphasizing patient choice: the modality selection project in ESRD Network 18.
- Controversies in iron management.
- Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.
- Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.
- Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients.
- Disease management improves outcomes in patients with CKD.
- Anemia: not just an innocent bystander?
- L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
- Determinants in APD selection.
- Dosing darbepoetin alfa.
- Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients.
- Dialysis in nursing homes.
- Utilizing a disease management approach to improve ESRD patient outcomes.
- Darbepoetin Alfa: A Viewpoint by Allen R. Nissenson.
Schools
Northwestern University The Feinberg School Of Medicine
Michael Reese Hospital and Med Center
Northwestern University
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Fellow (ASNF)
- Whos Who in Medicine and Healthcare
Education
-
Northwestern University Feinberg School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Alan D. Dauer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Z. Little III, MD |
|
Dr. Bruce A. Greenfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eben I. Feinstein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph A. Abdelmalek, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ramy M. Hanna, MD |
|
|
Dr. Hosameldin Madkour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ira B. Kurtz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ankit V. Shah, MD |
|
|
Dr. Rafael Villicana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roland L. Lee, MD |